For: | Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2013; 19(24): 3872-3882 [PMID: 23840128 DOI: 10.3748/wjg.v19.i24.3872] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i24/3872.htm |
Number | Citing Articles |
1 |
Astrid Bauschke, Annelore Altendorf-Hofmann, Michael Ardelt, Herman Kissler, Hans-Michael Tautenhahn, Utz Settmacher. Impact of successful local ablative bridging therapy prior to liver transplantation on long-term survival in patients with hepatocellular carcinoma in cirrhosis. Journal of Cancer Research and Clinical Oncology 2020; 146(7): 1819 doi: 10.1007/s00432-020-03215-9
|
2 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Clinical and Molecular Hepatology 2022; 28(4): 583 doi: 10.3350/cmh.2022.0294
|
3 |
P. Chevallier, G. Baudin, R. Anty, A. Guibal, M. Chassang, L. Avril, A. Tran. Traitement des carcinomes hépatocellulaires par thermodestruction et chimioembolisation intra-artérielle hépatique. Journal de Radiologie Diagnostique et Interventionnelle 2015; 96(2): 192 doi: 10.1016/j.jradio.2015.04.003
|
4 |
Zhimei Huang, Yangkui Gu, Shaoyong Wu, Chunxiao Lai, Xiuchen Wang, Jinhua Huang. Computed tomography-guided radiofrequency ablation of the retained iodized oil after simultaneous combination with transarterial embolization in small recurrent or residual hepatocellular carcinoma. Journal of Interventional Medicine 2020; 3(1): 49 doi: 10.1016/j.jimed.2020.01.008
|
5 |
|
6 |
A.H. Mahnken. Transarterielle ablative Therapien des hepatozellulären Karzinoms. Der Radiologe 2014; 54(7): 685 doi: 10.1007/s00117-014-2655-1
|
7 |
Zhenyin Liu, Fei Gao, Guang Yang, Sristi Singh, Mingjian Lu, Tao Zhang, Zhihui Zhong, Fujun Zhang, Rijie Tang. Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: an up-to-date meta-analysis. Tumor Biology 2014; 35(8): 7407 doi: 10.1007/s13277-014-1976-z
|
8 |
Wei Yuan, Min-Jie Yang, Jiang Xu, Zhi-Ping Yan, Rong Liu, Xu-Dong Qu, Jian-Hua Wang, Sheng Qian. Radiofrequency Ablation Combined With Transarterial Chemoembolization for Specially Located Small Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2018; 17 doi: 10.1177/1533033818788529
|
9 |
Li Wang, Min Yao, Zhizhen Dong, Yun Zhang, Dengfu Yao. Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring. Tumor Biology 2014; 35(1): 9 doi: 10.1007/s13277-013-1141-0
|
10 |
Xiaofeng Li, Dong Dai, Xiuyu Song, Jianjing Liu, Lei Zhu, Wengui Xu. A meta-analysis of cytokine-induced killer cells therapy in combination with minimally invasive treatment for hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2014; 38(5): 583 doi: 10.1016/j.clinre.2014.04.010
|
11 |
Derek M. Biederman, Joseph J. Titano, Vivian L. Bishay, Raisa J. Durrani, Etan Dayan, Nora Tabori, Rahul S. Patel, Francis S. Nowakowski, Aaron M. Fischman, Edward Kim. Radiation Segmentectomy versus TACE Combined with Microwave Ablation for Unresectable Solitary Hepatocellular Carcinoma Up to 3 cm: A Propensity Score Matching Study. Radiology 2017; 283(3): 895 doi: 10.1148/radiol.2016160718
|
12 |
KLCA Korean Liver Cancer Association, NCC National Cancer Center. 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut and Liver 2019; 13(3): 227 doi: 10.5009/gnl19024
|
13 |
Takeru Ohtaka, Shintaro Shiba, Kei Shibuya, Shohei Okazaki, Yuhei Miyasaka, Kento Tomizawa, Masahiko Okamoto, Tatsuya Ohno. Long-term survivor of hepatocellular carcinoma treated with repeated carbon ion radiotherapy and transarterial chemoembolization: a case report. Clinical Journal of Gastroenterology 2022; 15(4): 771 doi: 10.1007/s12328-022-01642-4
|
14 |
Rina Tsutsui, Hiroaki Nagamatsu, Naohisa Mizukami, Ziro Watanabe, Akihiro Deguchi, Satoru Morita, Noriyuki Ono. Rapid progression of hepatocellular carcinomas after combined transcatheter arterial chemoembolization and stereotactic body radiotherapy for a primary tumor in the liver. Kanzo 2014; 55(8): 503 doi: 10.2957/kanzo.55.503
|
15 |
Antonio Facciorusso, Michele Barone. Hepatocellular Carcinoma. 2016; : 453 doi: 10.1007/978-3-319-34214-6_30
|
16 |
Alexander Gerbes, Fabien Zoulim, Herbert Tilg, Jean-François Dufour, Jordi Bruix, Valérie Paradis, Riad Salem, Markus Peck-Radosavljevic, Peter R Galle, Tim F Greten, Jean-Charles Nault, Matias A Avila. Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. Gut 2018; 67(2): 380 doi: 10.1136/gutjnl-2017-315068
|
17 |
Mohit Girotra, Kaartik Soota, Amaninder S Dhaliwal, Rtika R Abraham, Mauricio Garcia-Saenz-de-Sicilia, Benjamin Tharian. Utility of endoscopic ultrasound and endoscopy in diagnosis and management of hepatocellular carcinoma and its complications: What does endoscopic ultrasonography offer above and beyond conventional cross-sectional imaging?. World Journal of Gastrointestinal Endoscopy 2018; 10(2): 56-68 doi: 10.4253/wjge.v10.i2.56
|
18 |
Qi Wang, Biyu Liu, Wenying Qiao, Jianjun Li, Chunwang Yuan, Jiang Long, Caixia Hu, Chaoran Zang, Jiasheng Zheng, Yonghong Zhang. The Dynamic Changes of AFP From Baseline to Recurrence as an Excellent Prognostic Factor of Hepatocellular Carcinoma After Locoregional Therapy: A 5-Year Prospective Cohort Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.756363
|
19 |
De-jun Yang, Kun-lun Luo, Hong Liu, Bing Cai, Guo-qing Tao, Xiao-fang Su, Xiao-juan Hou, Fei Ye, Xiang-yong Li, Zhi-qiang Tian. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma. Oncotarget 2017; 8(2): 2960 doi: 10.18632/oncotarget.13813
|
20 |
Eli Sapir, Eman ElAlfy, Paula Novelli, Mary Feng. Liver cancer turf wars. Applied Radiation Oncology 2015; : 8 doi: 10.37549/ARO1057
|
21 |
Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi. Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer Association. Journal of Liver Cancer 2024; 24(2): 131 doi: 10.17998/jlc.2024.08.04
|
22 |
Antonio Saviano, Roberto Iezzi, Felice Giuliante, Lucia Salvatore, Caterina Mele, Alessandro Posa, Francesco Ardito, Anna Maria De Gaetano, Maurizio Pompili, Emanuele Rinninella, Maria Assunta Zocco, Laura Riccardi, Brigida Eleonora Annicchiarico, Massimo Siciliano, Nicoletta De Matthaeis, Antonio Grieco, Gian Ludovico Rapaccini, Antonio Gasbarrini. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2017; 28(11): 1512 doi: 10.1016/j.jvir.2017.06.016
|
23 |
Jie‐Yu Yan, Jin‐Long Zhang, Mao‐Qiang Wang, Kai Yuan, Yan‐Hua Bai, Yan Wang, Hai‐Nan Xin, Zhi‐Jun Wang, Feng‐Yong Liu, Feng Duan, Jin‐Xin Fu. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single‐session for solitary hepatocellular carcinoma larger than 7 cm. Asia-Pacific Journal of Clinical Oncology 2018; 14(4): 300 doi: 10.1111/ajco.12817
|
24 |
Antonio Facciorusso, Gaetano Serviddio, Nicola Muscatiello. Local ablative treatments for hepatocellular carcinoma: An updated review. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(4): 477-489 doi: 10.4292/wjgpt.v7.i4.477
|
25 |
Li-Qun Zou, Bing-Lan Zhang, Qing Chang, Fu-Ping Zhu, Yan-Yan Li, Yu-Quan Wei, Yong-Song Guan. 3D conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. World Journal of Gastroenterology 2014; 20(45): 17227-17234 doi: 10.3748/wjg.v20.i45.17227
|
26 |
Olivier Seror, Gisèle N’Kontchou, Jean-Charles Nault, Yacine Rabahi, Pierre Nahon, Nathalie Ganne-Carrié, Véronique Grando, Nora Zentar, Michel Beaugrand, Jean-Claude Trinchet, Abou Diallo, Nicolas Sellier. Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment—Long-term Results. Radiology 2016; 280(2): 611 doi: 10.1148/radiol.2016150743
|
27 |
Fatih Boyvat. Local Ablation for Hepatocellular Carcinoma. Experimental and Clinical Transplantation 2014; 12(Suppl 1): 55 doi: 10.6002/ect.25Liver.L52
|
28 |
Pankaj Gupta, Shyamkumar N. Keshava, Naveen Kalra, Sreedhara B. Chaluvashetty, Amar Mukund, Shuvro H. Roy-Choudhury, Sanjay Saran Baijal, Anubhav Khandelwal, Venkatesh Hosur Ananthashayana, Sathya Narayanan R., Suyash S. Kulkarni, Nitin Sudhakar Shetty, Arun Gupta, Sanjay Gupta. Indian Society of Vascular and Interventional Radiology Expert Consensus Statements for Ablation in Hepatocellular Carcinoma: Part II. Journal of Clinical Interventional Radiology ISVIR 2020; 4(03): 175 doi: 10.1055/s-0040-1715775
|
29 |
Nathan X. Chai, Julius Chapiro. Therapy of Intermediate-Stage Hepatocellular Carcinoma: Current Evidence and Clinical Practice. Seminars in Interventional Radiology 2020; 37(05): 456 doi: 10.1055/s-0040-1719186
|
30 |
Laura M. Kulik, Attasit Chokechanachaisakul. Evaluation and Management of Hepatocellular Carcinoma. Clinics in Liver Disease 2015; 19(1): 23 doi: 10.1016/j.cld.2014.09.002
|
31 |
Yao Yu, Mary Feng. Radiotherapy for Hepatocellular Carcinoma. Seminars in Radiation Oncology 2018; 28(4): 277 doi: 10.1016/j.semradonc.2018.06.005
|
32 |
Nathan X. Chai, Julius Chapiro, Alexandra Petukhova, Moritz Gross, Ahmet Kucukkaya, Rajiv Raju, Tal Zeevi, Mohamed Elbanan, MingDe Lin, Juan Carlos Perez-Lozada, Todd Schlachter, Mario Strazzabosco, Jeffrey S. Pollak, David C. Madoff. Thermal ablation alone vs thermal ablation combined with transarterial chemoembolization for patients with small (<3 cm) hepatocellular carcinoma. Clinical Imaging 2021; 76: 123 doi: 10.1016/j.clinimag.2021.01.043
|
33 |
Song Wang, Xing-Guo Mei, S. Nahum Goldberg, Muneeb Ahmed, Jung-Chieh Lee, Wei Gong, Hai-Bo Han, Kun Yan, Wei Yang. Does Thermosensitive Liposomal Vinorelbine Improve End-Point Survival after Percutaneous Radiofrequency Ablation of Liver Tumors in a Mouse Model?. Radiology 2016; 279(3): 762 doi: 10.1148/radiol.2015150787
|
34 |
Steven D. Colquhoun. Hepatocellular carcinoma clinical update: Current standards and therapeutic strategies. Liver Research 2020; 4(4): 180 doi: 10.1016/j.livres.2020.11.004
|
35 |
Dongho Hyun, Sung Ki Cho, Sung Wook Shin, Kwang Bo Park, Hong Suk Park, Sung Wook Choo, Young Soo Do, In-wook Choo, Min Woo Lee, Hyunchul Rhim, Hyo Keun Lim. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation. CardioVascular and Interventional Radiology 2016; 39(3): 417 doi: 10.1007/s00270-015-1194-0
|
36 |
Won Hyeok Choe, Young Jun Kim, Hee Sun Park, Sang Woo Park, Jeong Han Kim, So Young Kwon. Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinoma. World Journal of Gastroenterology 2014; 20(35): 12588-12594 doi: 10.3748/wjg.v20.i35.12588
|
37 |
R. Ciria, P. López-Cillero, A.-B. Gallardo, J. Cabrera, M. Pleguezuelo, M.-D. Ayllón, A. Luque, L. Zurera, J.-J. Espejo, M. Rodríguez-Perálvarez, J.-L. Montero, M. de la Mata, J. Briceño. Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization. European Journal of Surgical Oncology (EJSO) 2015; 41(9): 1153 doi: 10.1016/j.ejso.2015.05.023
|
38 |
Stacey Prenner, Laura Kulik. Zakim and Boyer's Hepatology. 2018; : 668 doi: 10.1016/B978-0-323-37591-7.00046-X
|
39 |
Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi. Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association. Korean Journal of Radiology 2024; 25(9): 773 doi: 10.3348/kjr.2024.0550
|
40 |
2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 2015; 16(3): 465 doi: 10.3348/kjr.2015.16.3.465
|
41 |
Sirish Kishore, Tamir Friedman, David C. Madoff. Update on Embolization Therapies for Hepatocellular Carcinoma. Current Oncology Reports 2017; 19(6) doi: 10.1007/s11912-017-0597-2
|
42 |
Nora E. Tabori, Gajan Sivananthan. Treatment Options for Early-Stage Hepatocellular Carcinoma. Seminars in Interventional Radiology 2020; 37(05): 448 doi: 10.1055/s-0040-1720950
|
43 |
J. Bornschein, S. Schlosser, A. G. Schreyer, M. Müller-Schilling. Das hepatozelluläre Karzinom. Der Gastroenterologe 2016; 11(5): 368 doi: 10.1007/s11377-016-0101-9
|
44 |
Pascale Tinguely, Marius Schwalbe, Torsten Fuss, Dominik P. Guensch, Andreas Kohler, Iris Baumgartner, Stefan Weber, Daniel Candinas, Gianfranco D. Alpini. Multi-Operational Selective Computer-Assisted Targeting of hepatocellular carcinoma—Evaluation of a novel approach for navigated tumor ablation. PLOS ONE 2018; 13(5): e0197914 doi: 10.1371/journal.pone.0197914
|
45 |
Stacy K. Y. Fan, Brian Li, Qingyang Chen, Mehran Midia. Impact of Interventional Oncology Therapies on Tumor Microenvironment and Strategies to Enhance Their Efficacy. American Journal of Roentgenology 2018; 210(3): 648 doi: 10.2214/AJR.16.17677
|
46 |
Michael Ginsburg, Sean P. Zivin, Kristen Wroblewski, Taral Doshi, Raj J. Vasnani, Thuong G. Van Ha. Comparison of Combination Therapies in the Management of Hepatocellular Carcinoma: Transarterial Chemoembolization with Radiofrequency Ablation versus Microwave Ablation. Journal of Vascular and Interventional Radiology 2015; 26(3): 330 doi: 10.1016/j.jvir.2014.10.047
|
47 |
Peter R. Galle, Francesco Tovoli, Friedrich Foerster, Marcus A. Wörns, Alessandro Cucchetti, Luigi Bolondi. The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy. Journal of Hepatology 2017; 67(1): 173 doi: 10.1016/j.jhep.2017.03.007
|
48 |
Robert R. McMillan, Vatche G. Agopian. The Critically Ill Cirrhotic Patient. 2020; : 237 doi: 10.1007/978-3-030-24490-3_13
|
49 |
Hao Wu, Zhi-Pu Fan, An-Na Jiang, Xing-Sheng Di, Bing He, Song Wang, S. Nahum Goldberg, Muneeb Ahmed, Qiang Zhang, Wei Yang. Combination of intratumoural micellar paclitaxel with radiofrequency ablation: efficacy and toxicity in rodents. European Radiology 2019; 29(11): 6202 doi: 10.1007/s00330-019-06207-7
|
50 |
Hui Xie, Huaming Wang, Weimin An, Wei Ma, Ruping Qi, Bin Yang, Chunzi Liu, Yuanzhi Gao, Beibei Xu, Wenhong Wang, Andreas-Claudius Hoffmann. The Efficacy of Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for Primary Hepatocellular Carcinoma in a Cohort of 487 Patients. PLoS ONE 2014; 9(2): e89081 doi: 10.1371/journal.pone.0089081
|
51 |
Peng Yuan, Fei Wang, Guangyu Zhu, Baoan Chen. The clinical efficiency of TACE combined with simultaneous computed tomography‐guided radiofrequency ablation for advanced hepatocellular carcinoma. Investigational New Drugs 2021; 39(5): 1383 doi: 10.1007/s10637-021-01101-w
|
52 |
Merve Ozen, Ronak K. Patel. Ablation versus Radiation Segmentectomy for Small Liver Tumors. Seminars in Interventional Radiology 2023; 40(06): 511 doi: 10.1055/s-0043-1777714
|
53 |
Roberto Iezzi, Maurizio Pompili, Alessandro Posa, Giuseppe Coppola, Antonio Gasbarrini, Lorenzo Bonomo. Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art. World Journal of Gastroenterology 2016; 22(6): 1935-1942 doi: 10.3748/wjg.v22.i6.1935
|
54 |
Mohamed A Chinnaratha, Ming‐yu Anthony Chuang, Robert JL Fraser, Richard J Woodman, Alan J Wigg. Percutaneous thermal ablation for primary hepatocellular carcinoma: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2016; 31(2): 294 doi: 10.1111/jgh.13028
|
55 |
Giovan Giuseppe Di Costanzo, Giampiero Francica, Claudio Maurizio Pacella. Laser ablation for small hepatocellular carcinoma: State of the art and future perspectives. World Journal of Hepatology 2014; 6(10): 704-715 doi: 10.4254/wjh.v6.i10.704
|
56 |
Xiao-Hui Zhao, Hai-Liang Li, Chen-Yang Guo, Quan-Jun Yao, Wei-Li Xia, Hong-Tao Hu. Downstaging and Conversation Strategy for Advanced Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus: TACE, 125I Seed Implantation, and RFA for Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus. Journal of Hepatocellular Carcinoma 2023; : 231 doi: 10.2147/JHC.S392293
|
57 |
Ender Gunes Yegin, Erkan Oymaci, Emrah Karatay, Ahmet Coker. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment. Hepatobiliary & Pancreatic Diseases International 2016; 15(3): 234 doi: 10.1016/S1499-3872(16)60097-8
|
58 |
Kun Zhao, Hao Wu, Wei Yang, Yuxi Cheng, Song Wang, An-na Jiang, Kun Yan, S Nahum Goldberg. Can two-step ablation combined with chemotherapeutic liposomes achieve better outcome than traditional RF ablation? A solid tumor animal study. Nanoscale 2022; 14(17): 6312 doi: 10.1039/D1NR08125J
|
59 |
Giovan Giuseppe Di Costanzo, Raffaella Tortora. Intermediate hepatocellular carcinoma: How to choose the best treatment modality?. World Journal of Hepatology 2015; 7(9): 1184-1191 doi: 10.4254/wjh.v7.i9.1184
|
60 |
Chuang Jiang, Gong Cheng, Mingheng Liao, Jiwei Huang. Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02188-4
|
61 |
Young‐Il Kim, Joong‐Won Park, Hee‐Won Kwak, Bo Hyun Kim, Ju Hee Lee, In Joon Lee, Tae Hyun Kim, Seong Hoon Kim, Young Hwan Koh, Hyun Beom Kim, Chang‐Min Kim. Long‐term outcomes of second treatment after initial transarterial chemoembolization in patients with hepatocellular carcinoma. Liver International 2014; 34(8): 1278 doi: 10.1111/liv.12535
|
62 |
Ming-Jeng Kuo, Lein-Ray Mo, Chi-Ling Chen. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07948-9
|
63 |
Dong Ik Cha, Min Woo Lee, Dongho Hyun, Soo Hyun Ahn, Woo Kyoung Jeong, Hyunchul Rhim. Combined Transarterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Infeasible for Ultrasound-Guided Percutaneous Radiofrequency Ablation: A Comparative Study with General Ultrasound-Guided Radiofrequency Ablation Outcomes. Cancers 2023; 15(21): 5193 doi: 10.3390/cancers15215193
|
64 |
Qi-Wen Chen, Hai-Feng Ying, Song Gao, Ye-Hua Shen, Zhi-Qiang Meng, Hao Chen, Zhen Chen, Wen-Jing Teng. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2016; 40(3): 309 doi: 10.1016/j.clinre.2015.07.008
|
65 |
Mahmoud A. Dawoud, Rania E. Mohamed, Mohamed S. El Waraki, Ahmed M. Gabr. Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinoma. The Egyptian Journal of Radiology and Nuclear Medicine 2017; 48(4): 935 doi: 10.1016/j.ejrnm.2017.06.005
|
66 |
Shi-yan Li, Pin-tong Huang, Yong Fang, Yao Wu, Ling Zhou, Jie-li Luo, Xian-chen Wang, Yun-chong Chen. Ultrasonic Cavitation Ameliorates Antitumor Efficacy of Residual Cancer After Incomplete Radiofrequency Ablation in Rabbit VX2 Liver Tumor Model. Translational Oncology 2019; 12(8): 1113 doi: 10.1016/j.tranon.2019.05.007
|
67 |
Kana Yamazaki, Ryuichi Nishii, Yoichi Mizutani, Hirokazu Makishima, Takashi Kaneko, Yoshiharu Isobe, Tamasa Terada, Kentaro Tamura, Etsuko Imabayashi, Toshiaki Tani, Masato Kobayashi, Masaru Wakatsuki, Hiroshi Tsuji, Tatsuya Higashi. Estimation of post-therapeutic liver reserve capacity using 99mTc-GSA scintigraphy prior to carbon-ion radiotherapy for liver tumors. European Journal of Nuclear Medicine and Molecular Imaging 2023; 50(2): 581 doi: 10.1007/s00259-022-05985-5
|
68 |
YiFeng Wu, ChaoYong Tu, ChuXiao Shao. Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy. BMC Surgery 2021; 21(1) doi: 10.1186/s12893-021-01180-9
|
69 |
Vincenza Granata, Roberta Fusco, Valeria D’Alessio, Igino Simonetti, Francesca Grassi, Lucrezia Silvestro, Raffaele Palaia, Andrea Belli, Renato Patrone, Mauro Piccirillo, Francesco Izzo. Percutanous Electrochemotherapy (ECT) in Primary and Secondary Liver Malignancies: A Systematic Review. Diagnostics 2023; 13(2): 209 doi: 10.3390/diagnostics13020209
|
70 |
Yaoping Shi, Bo Zhai. A Recent Advance in Image-Guided Locoregional Therapy for Hepatocellular Carcinoma. Gastrointestinal Tumors 2016; 3(2): 90 doi: 10.1159/000445888
|
71 |
Zhentian Xu, Haiyang Xie, Lin Zhou, Xinhua Chen, Shusen Zheng. The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma. Analytical Cellular Pathology 2019; 2019: 1 doi: 10.1155/2019/8619096
|
72 |
Xingshun Qi, Yan Zhao, Hongyu Li, Xiaozhong Guo, Guohong Han. Management of hepatocellular carcinoma: an overview of major findings from meta-analyses. Oncotarget 2016; 7(23): 34703 doi: 10.18632/oncotarget.9157
|
73 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Journal of Liver Cancer 2023; 23(1): 1 doi: 10.17998/jlc.2022.11.07
|
74 |
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 2019; 20(7): 1042 doi: 10.3348/kjr.2019.0140
|
75 |
Özgür Özen, Fatih Boyvat, Tolga Zeydanlı, Çağrı Kesim, Emre Karakaya, Mehmet Haberal. Transarterial Chemoembolization Combined with Simultaneous Thermal Ablation for Solitary Hepatocellular Carcinomas in Regions with a High Risk of Recurrence. Experimental and Clinical Transplantation 2023; 21(6): 512 doi: 10.6002/ect.2023.0078
|
76 |
Francesco Bellissimo, Marilia Rita Pinzone, Bruno Cacopardo, Giuseppe Nunnari. Diagnostic and therapeutic management of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12003-12021 doi: 10.3748/wjg.v21.i42.12003
|
77 |
Hongyan Shao, Juan Deng, Luping Xie, Qiwen Zheng, Bihui Zou, Jun Deng, Tianqi Zhang, Jingjing He. Influencing factors related to transcatheter arterial chemoembolization for hepatocellular carcinoma patients achieved tumor response. Journal of Cancer Research and Therapeutics 2022; 18(2): 560 doi: 10.4103/jcrt.jcrt_852_21
|
78 |
Xin Wang, Yanan Hu, Mudan Ren, Xinlan Lu, Guifang Lu, Shuixiang He. Efficacy and Safety of Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinomas Compared with Radiofrequency Ablation Alone: A Time-to-Event Meta-Analysis. Korean Journal of Radiology 2016; 17(1): 93 doi: 10.3348/kjr.2016.17.1.93
|
79 |
M. Miguet, J.P. Adam, J.F. Blanc, B. Lapuyade, P. Bernard, E. Buscail, M. Neau-Cransac, V. Vendrely, C. Laurent, L. Chiche. Multidisciplinary meetings specific to hepatocellular carcinoma: How to proceed?. Journal of Visceral Surgery 2019; 156(3): 217 doi: 10.1016/j.jviscsurg.2018.09.007
|
80 |
Matteo Renzulli, Francesco Tovoli, Alfredo Clemente, Anna Maria Ierardi, Irene Pettinari, Giuliano Peta, Giovanni Marasco, Davide Festi, Fabio Piscaglia, Salvatore Cappabianca, Gianpaolo Carrafiello, Rita Golfieri. Ablation for hepatocellular carcinoma: beyond the standard indications. Medical Oncology 2020; 37(4) doi: 10.1007/s12032-020-01348-y
|
81 |
Kei Endo, Hidekatsu Kuroda, Takayoshi Oikawa, Yohei Okada, Yudai Fujiwara, Tamami Abe, Hiroki Sato, Kei Sawara, Yasuhiro Takikawa. Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 2018; 53(12): 1575 doi: 10.1080/00365521.2018.1548645
|
82 |
C.M. Sommer, U. Stampfl, H.U. Kauczor, P.L. Pereira. Nationale S3-Leitlinie hepatozelluläres Karzinom. Der Radiologe 2014; 54(7): 642 doi: 10.1007/s00117-014-2656-0
|
83 |
Lin Wang, Bao-Xian Liu, Hai-Yi Long. Ablative strategies for recurrent hepatocellular carcinoma. World Journal of Hepatology 2023; 15(4): 515-524 doi: 10.4254/wjh.v15.i4.515
|
84 |
Pankaj Gupta, Naveen Kalra, Sreedhara B. Chaluvashetty, Shivanand Gamangatti, Amar Mukund, Razik Abdul, VS Shyam, Sanjay Saran Baijal, Chander Mohan. Indian College of Radiology and Imaging Guidelines on Interventions in Hepatocellular Carcinoma. Indian Journal of Radiology and Imaging 2022; 32(04): 540 doi: 10.1055/s-0042-1754361
|
85 |
T. L. Gockner, S. Zelzer, T. Mokry, D. Gnutzmann, N. Bellemann, C. Mogler, A. Beierfuß, E. Köllensperger, G. Germann, B. A. Radeleff, U. Stampfl, H. U. Kauczor, P. L. Pereira, C. M. Sommer. Sphere-Enhanced Microwave Ablation (sMWA) Versus Bland Microwave Ablation (bMWA): Technical Parameters, Specific CT 3D Rendering and Histopathology. CardioVascular and Interventional Radiology 2015; 38(2): 442 doi: 10.1007/s00270-014-0964-4
|
86 |
Jun Sik Yoon, Gyeonghwa Kim, Yu Rim Lee, Soo Young Park, Won Young Tak, Young-Oh Kweon, Jung Gil Park, Hye Won Lee, Young Seok Han, Heon Tak Ha, Jae Min Chun, Se Young Jang, Keun Hur. Clinical Significance of Microrna-21 Expression in Disease Progression of Patients With Hepatocellular Carcinoma. Biomarkers in Medicine 2018; 12(10): 1105 doi: 10.2217/bmm-2018-0096
|
87 |
Qiu-song Liu, Que-lin Mei, Yan-hao Li. Polyvinyl alcohol terminal chemoembolization for hepatocellular carcinoma with hepatic arteriovenous shunts: Safety, efficacy, and prognostic factors. European Journal of Radiology 2017; 89: 277 doi: 10.1016/j.ejrad.2016.04.016
|
88 |
Shakira Hoque, Christy Kim, Mihir Desai, Pram Sirimana, Malin Katarina Schumacher, Sri Jasti, Mostafa Abasseri, Oliver M.Fisher, Francis Chu, Suhrid Lodh, Natalie Collier, Winston Liauw, Piotr Milkiewicz, Amany Zekry. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; : 321 doi: 10.1002/9781119756422.ch18
|
89 |
Dongho Hyun, Sung Ki Cho, Sung Wook Shin, Hyunchul Rhim, Kwang Cheol Koh, Seung Woon Paik. Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation. CardioVascular and Interventional Radiology 2016; 39(7): 1015 doi: 10.1007/s00270-016-1314-5
|
90 |
Zeno Sparchez, Pompilia Radu, Adrian Bartos, Iuliana Nenu, Rares Craciun, Tudor Mocan, Adelina Horhat, Mihaela Spârchez, Jean-François Dufour. Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?. World Journal of Gastrointestinal Oncology 2021; 13(12): 1896-1918 doi: 10.4251/wjgo.v13.i12.1896
|
91 |
Roberto Iezzi, Alessandro Posa, Alessandro Tanzilli, Francesca Carchesio, Maurizio Pompili, Riccardo Manfredi. Balloon-Occluded MWA (b-MWA) Followed by Balloon-Occluded TACE (b-TACE): Technical Note on a New Combined Single-Step Therapy for Single Large HCC. CardioVascular and Interventional Radiology 2020; 43(11): 1702 doi: 10.1007/s00270-020-02583-6
|
92 |
Liangliang Yan, Yanqiao Ren, Kun Qian, Xuefeng Kan, Hongsen Zhang, Lei Chen, Bin Liang, Chuansheng Zheng. Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01765-x
|
93 |
Wenying Qiao, Qi Wang, Tingting Mei, Qi Wang, Wen Wang, Yonghong Zhang. External validation and improvement of the scoring system for predicting the prognosis in hepatocellular carcinoma after interventional therapy. Frontiers in Surgery 2023; 10 doi: 10.3389/fsurg.2023.1045213
|
94 |
Alessandra Mazzola, Andrea Costantino, Salvatore Petta, Tommaso Vincenzo Bartolotta, Maurizio Raineri, Rodolfo Sacco, Giuseppe Brancatelli, Calogero Cammà, Giuseppe Cabibbo. Recurrence of Hepatocellular Carcinoma after Liver Transplantation: An Update. Future Oncology 2015; 11(21): 2923 doi: 10.2217/fon.15.239
|
95 |
Ying Wei, Xiao ling Yu. Microwave Ablation Treatment of Solid Tumors. 2015; : 41 doi: 10.1007/978-94-017-9315-5_4
|
96 |
Hyukjoon Lee, Chang Jin Yoon, Nak Jong Seong, Sook-Hyang Jeong, Jin-Wook Kim. Comparison of Combined Therapy Using Conventional Chemoembolization and Radiofrequency Ablation Versus Conventional Chemoembolization for Ultrasound-Invisible Early-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Cancer Stage 0 or A). Korean Journal of Radiology 2018; 19(6): 1130 doi: 10.3348/kjr.2018.19.6.1130
|
97 |
David Li, Josephine Kang, David C Madoff. Locally ablative therapies for primary and metastatic liver cancer. Expert Review of Anticancer Therapy 2014; 14(8): 931 doi: 10.1586/14737140.2014.911091
|
98 |
Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi. Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association. Gut and Liver 2024; 18(5): 789 doi: 10.5009/gnl240350
|
99 |
Dong Ho Lee, Jeong Min Lee. Recent Advances in the Image-Guided Tumor Ablation of Liver Malignancies: Radiofrequency Ablation with Multiple Electrodes, Real-Time Multimodality Fusion Imaging, and New Energy Sources. Korean Journal of Radiology 2018; 19(4): 545 doi: 10.3348/kjr.2018.19.4.545
|
100 |
Zainul Abedin Kapacee, Nicola de Liguori Carino, Angela Lamarca, Richard A. Hubner, Juan W. Valle, Mairéad G. McNamara. Frailty in Older Adults with Cancer. 2022; : 421 doi: 10.1007/978-3-030-89162-6_24
|
101 |
Chiara Floridi, Laura Maria Cacioppa, Nicolò Rossini, Marco Macchini, Alessandra Bruno, Andrea Agostini, Valeria Consoli, Riccardo Inchingolo, Fabrizio Acquafredda, Daniele Nicolini, Laura Schiadà, Gianluca Svegliati Baroni, Roberto Candelari. Microwave ablation followed by cTACE in 5-cm HCC lesions: does a single-session approach affect liver function?. La radiologia medica 2024; 129(8): 1252 doi: 10.1007/s11547-024-01842-7
|
102 |
Yulan Wang, Tianxing Deng, Li Zeng, Weiqing Chen. Efficacy and safety of radiofrequency ablation and transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: A meta‐analysis. Hepatology Research 2016; 46(1): 58 doi: 10.1111/hepr.12568
|
103 |
B. N. Kotiv, I. I. Dzidzava, S. A. Alent’yev, A. V. Smorodsky, K. I. Makhmudov, A. A. Apollonov, S. A. Soldatov, P. N. Zubarev. Complex treatment of hepatocellular carcinoma at early (BCLC-A) and intermediate (BCLC-B) stages. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2020; 25(2): 55 doi: 10.16931/1995-5464.2020255-66
|
104 |
Masaya Miyazaki, Toshihiro Iguchi, Haruyuki Takaki, Takashi Yamanaka, Yoshitaka Tamura, Hiroyuki Tokue, Yozo Sato, Osamu Ikeda, Tadashi Shimizu, Koichiro Yamakado. Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts. Japanese Journal of Radiology 2016; 34(9): 647 doi: 10.1007/s11604-016-0569-8
|
105 |
Xinli Huang, Sen Lu. Impact of preoperative locoregional therapy on recurrence and patient survival following liver transplantation for hepatocellular carcinoma: a meta-analysis. Scandinavian Journal of Gastroenterology 2017; 52(2): 143 doi: 10.1080/00365521.2016.1236396
|
106 |
B. I. Dolgushin, V. Yu. Kosyrev, E. R. Virshke, V. N. Sholokhov, D. V. Martynkov. Radiofrequency thermal destruction in current treatment of liver malignancies. Literature review. Annaly khirurgicheskoy gepatologii = Annals of HPB surgery 2018; 23(2): 11 doi: 10.16931/1995-5464.2018211-25
|
107 |
Xiao Wu, Ryan Peter Lokken, Neil Mehta. Optimal treatment for small HCC (<3 cm): Resection, liver transplantation, or locoregional therapy?. JHEP Reports 2023; 5(8): 100781 doi: 10.1016/j.jhepr.2023.100781
|
108 |
Masashi Hirooka, Atsushi Hiraoka, Hironori Ochi, Yoshiyasu Kisaka, Kouji Joko, Kojiro Michitaka, Yoichi Hiasa. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma. American Journal of Roentgenology 2018; 210(4): 891 doi: 10.2214/AJR.17.18177
|
109 |
Amanda R. Smolock, Mircea M. Cristescu, Audrey Hinshaw, Kaitlin M. Woo, Shane A. Wells, Timothy J. Ziemlewicz, Meghan G. Lubner, Prasad S. Dalvie, J. Louis Hinshaw, Christopher L. Brace, Orhan S. Ozkan, Fred T. Lee, Paul Laeseke. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone. Abdominal Radiology 2018; 43(9): 2497 doi: 10.1007/s00261-018-1464-9
|
110 |
Erica M. Knavel, Chelsey M. Green, Annette Gendron-Fitzpatrick, Christopher L. Brace, Paul F. Laeseke. Combination Therapies: Quantifying the Effects of Transarterial Embolization on Microwave Ablation Zones. Journal of Vascular and Interventional Radiology 2018; 29(7): 1050 doi: 10.1016/j.jvir.2018.01.785
|
111 |
Zeng Wang-Yuan, Zeng Jiang-Zheng, Yan-Da Lu, Xin-Bao Hao, Tao Hong, Fen Huang, Jun-Hua Lei, Zhi-Hui He, Mei-zhu Huang. Clinical efficacy of metronomic chemotherapy after cool-tip radiofrequency ablation in the treatment of hepatocellular carcinoma. International Journal of Hyperthermia 2016; 32(2): 193 doi: 10.3109/02656736.2015.1099168
|
112 |
Young Chang, Soung Won Jeong, Jae Young Jang, Yong Jae Kim. Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2020; 21(21): 8165 doi: 10.3390/ijms21218165
|
113 |
Sirish A. Kishore, Raazi Bajwa, David C. Madoff. Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update. Cancers 2020; 12(4): 791 doi: 10.3390/cancers12040791
|
114 |
Daniela Tabacelia, Cezar Stroescu, Radu Dumitru, Raluca Roxana Grigorescu, Alexandru Martiniuc, Ioana Alexandra Husar-Sburlan, Narcis Copca. New approach for hepatocellular carcinoma treatment. Journal of Medicine and Life 2022; 15(1): 138 doi: 10.25122/jml-2021-0088
|
115 |
P. Chevallier, G. Baudin, R. Anty, A. Guibal, M. Chassang, L. Avril, A. Tran. Treatment of hepatocellular carcinomas by thermal ablation and hepatic transarterial chemoembolization. Diagnostic and Interventional Imaging 2015; 96(6): 637 doi: 10.1016/j.diii.2015.04.006
|
116 |
Brendan LoGiurato, John Smirniotopoulos, Michael Darcy, Resmi A. Charalel. Gastrointestinal Interventions: Then and Now. Digestive Disease Interventions 2020; 4(04): 401 doi: 10.1055/s-0040-1721455
|
117 |
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 2022; 23(12): 1126 doi: 10.3348/kjr.2022.0822
|
118 |
Lumin Chen, Jihong Sun, Xiaoming Yang. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status. Cancer Letters 2016; 370(1): 78 doi: 10.1016/j.canlet.2015.09.020
|
119 |
M. Miguet, J.P. Adam, J.F. Blanc, B. Lapuyade, P. Bernard, E. Buscail, M. Neau-Cransac, V. Vendrely, C. Laurent, L. Chiche. Une réunion de concertation pluridisciplinaire (RCP) spécifique pour le carcinome hépatocellulaire (CHC) : mode d’emploi. Journal de Chirurgie Viscérale 2019; 156(3): 244 doi: 10.1016/j.jchirv.2018.08.009
|
120 |
Thaddeus J. Maguire, Aditya Shreenivas, William S. Rilling. Image-Guided Interventions in Oncology. 2020; : 81 doi: 10.1007/978-3-030-48767-6_6
|